SAB Biotherapeutics (SABS) Income Statement (2021 - 2026)
Income Statement report data from Mar 31, 2021 to Mar 31, 2026 for SAB Biotherapeutics (SABS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||
Total Revenue | - | - | - | - | - | 110K | - | 260K (-72.34%) | 940K (+203.23%) | 310K (-75.59%) | 1.27M (+1311.11%) | 90K (-84.48%) | 580K (-73.15%) | 2.16M (-39.83%) | 3.59M (-43.46%) | 6.35M (-46.19%) | 12M (+6.69%) | 11M (-24.66%) | 15M (-19.38%) | 18M (+7.56%) | 17M |
Operating Expenses | |||||||||||||||||||||
Research And Development | 13M (+24.88%) | 11M (+19.62%) | 8.97M (+28.14%) | 7.00M (-8.62%) | 7.66M (+2.82%) | 7.45M (-4.85%) | 7.83M (+14.81%) | 6.82M (-16.32%) | 8.15M (+89.53%) | 4.30M (+6.97%) | 4.02M (+9.84%) | 3.66M (-19.38%) | 4.54M (-36.77%) | 7.18M (-2.31%) | 7.35M (-14.34%) | 8.58M (-35.59%) | 13M (+25.07%) | 11M (-29.33%) | 15M (-19.33%) | 19M (+46.17%) | 13M |
Selling General And Administrative | 6.60M (+30.95%) | 5.04M (+35.85%) | 3.71M (+35.40%) | 2.74M (-11.90%) | 3.11M (+16.48%) | 2.67M (-23.28%) | 3.48M (-4.40%) | 3.64M (-13.13%) | 4.19M (-71.84%) | 15M (+478.99%) | 2.57M (-11.38%) | 2.90M (-15.94%) | 3.45M (+21.48%) | 2.84M (-29.70%) | 4.04M (-6.26%) | 4.31M (-16.96%) | 5.19M (-33.03%) | 7.75M (+115.28%) | 3.60M (+50.00%) | 2.40M (-27.93%) | 3.33M |
Operating Expenses | 20M (+26.82%) | 16M (+24.37%) | 13M (+30.32%) | 9.73M (-9.66%) | 11M (+6.42%) | 10M (-10.52%) | 11M (+8.13%) | 10M (-15.24%) | 12M (-35.66%) | 19M (+191.05%) | 6.59M (+0.46%) | 6.56M (-17.79%) | 7.98M (-20.36%) | 10M (-12.11%) | 11M (-11.56%) | 13M (-30.36%) | 19M (+0.60%) | 18M (-1.45%) | 19M (-11.43%) | 21M (+30.85%) | 16M |
Depreciation And Amortization | 730K (-1.35%) | 740K (+5.71%) | 700K (-12.50%) | 800K (+5.26%) | 760K (-9.52%) | 840K (-6.67%) | 900K (-10.00%) | 1.00M (-48.98%) | 1.96M (+130.59%) | 850K (-15.00%) | 1.00M (+11.11%) | 900K (0.00%) | 900K (+1.12%) | 890K (0.00%) | 890K (+18.67%) | 750K (+17.19%) | 640K (+3.23%) | 620K (+67.57%) | 370K (+42.31%) | 260K (+8.33%) | 240K |
Operating Income | |||||||||||||||||||||
Operating Income | -20.00M (+26.82%) | -15.77M (+24.37%) | -12.68M (+30.32%) | -9.73M (-9.66%) | -10.77M (+7.59%) | -10.01M (-11.49%) | -11.31M (+10.88%) | -10.20M (-10.45%) | -11.39M (-39.64%) | -18.87M (+254.70%) | -5.32M (-17.90%) | -6.48M (-12.43%) | -7.40M (-5.85%) | -7.86M (+0.64%) | -7.81M (+19.42%) | -6.54M (-2.53%) | -6.71M (-8.58%) | -7.34M (+83.96%) | -3.99M (+39.02%) | -2.87M | 810K |
Ebit | -20.00M (+26.82%) | -15.77M (+24.37%) | -12.68M (+30.32%) | -9.73M (-9.66%) | -10.77M (+7.59%) | -10.01M (-11.49%) | -11.31M (+10.88%) | -10.20M (-10.45%) | -11.39M (-39.64%) | -18.87M (+254.70%) | -5.32M (-17.90%) | -6.48M (-12.43%) | -7.40M (-5.85%) | -7.86M (+0.64%) | -7.81M (+19.42%) | -6.54M (-2.53%) | -6.71M (-8.58%) | -7.34M (+83.96%) | -3.99M (+39.02%) | -2.87M | 810K |
EBITDA | -19.27M (+28.21%) | -15.03M (+25.46%) | -11.98M (+34.15%) | -8.93M (-10.88%) | -10.02M (+9.27%) | -9.17M (-11.91%) | -10.41M (+13.15%) | -9.20M (-2.44%) | -9.43M (-47.67%) | -18.02M (+317.13%) | -4.32M (-22.58%) | -5.58M (-14.15%) | -6.50M (-6.74%) | -6.97M (+0.72%) | -6.92M (+19.52%) | -5.79M (-4.61%) | -6.07M (-9.67%) | -6.72M (+85.64%) | -3.62M (+38.70%) | -2.61M | 1.05M |
Other Income / Expenses | |||||||||||||||||||||
Interest Expense | 60K (0.00%) | 60K (+50.00%) | 40K (-33.33%) | 60K (-14.29%) | 70K (0.00%) | 70K (-12.50%) | 80K (-11.11%) | 90K (+12.50%) | 80K (0.00%) | 80K (+14.29%) | 70K (-12.50%) | 80K (-11.11%) | 90K (0.00%) | 90K (+28.57%) | 70K (0.00%) | 70K (0.00%) | 70K (0.00%) | 70K (-12.50%) | 80K (+14.29%) | 70K (-12.50%) | 80K |
Net Interest Income | - | - | - | - | - | 170K | - | -90.00K (+12.50%) | -80.00K (0.00%) | -80.00K (+14.29%) | -70.00K (-12.50%) | -80.00K (-11.11%) | -90.00K (0.00%) | -90.00K (+28.57%) | -70.00K (0.00%) | -70.00K (0.00%) | -70.00K (0.00%) | -70.00K (-12.50%) | -80.00K (+14.29%) | -70.00K (-12.50%) | -80.00K |
Other Non Operating Income | 1.13M (-98.18%) | 62M (+7.07%) | 58M | -380.00K | 5.58M (-36.66%) | 8.81M (+817.71%) | 960K (-66.55%) | 2.87M (-54.87%) | 6.36M | -4.12M | 220K | -400.00K | 50K (+66.67%) | 30K (-95.89%) | 730K (-56.29%) | 1.67M (-78.56%) | 7.79M (+77800.00%) | 10K | -70.00K (0.00%) | -70.00K | 600K |
Net Income | |||||||||||||||||||||
Income Before Tax | - | 13M | - | - | - | 23M | -10.35M (+41.01%) | -7.34M (+45.92%) | -5.03M (-78.00%) | -22.86M (+348.24%) | -5.10M (-25.87%) | -6.88M (-6.39%) | -7.35M (-6.37%) | -7.85M (+10.88%) | -7.08M (+45.38%) | -4.87M | 1.08M | -11.55M (+184.48%) | -4.06M (+38.10%) | -2.94M | 1.41M |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 30K | - | -90.00K | 90K | - | - | - | - |
Net Income From Continuing Operations | -18.87M (+11.92%) | -16.86M | 45M | -10.11M (+94.42%) | -5.20M (-54.35%) | -11.39M (+10.05%) | -10.35M (+41.01%) | -7.34M (+45.92%) | -5.03M (-78.00%) | -22.86M (+348.24%) | -5.10M (-25.87%) | -6.88M (-6.39%) | -7.35M (-6.61%) | -7.87M (+11.16%) | -7.08M (+48.12%) | -4.78M | 990K | -11.55M (+184.48%) | -4.06M (+38.10%) | -2.94M | 1.41M |
Net Income | -18.87M (+11.92%) | -16.86M | 45M | -10.11M (+94.42%) | -5.20M (-54.35%) | -11.39M (+10.05%) | -10.35M (+41.01%) | -7.34M (+45.92%) | -5.03M (-78.00%) | -22.86M (+348.24%) | -5.10M (-25.87%) | -6.88M (-6.39%) | -7.35M (-6.61%) | -7.87M (+11.16%) | -7.08M (+48.12%) | -4.78M | 990K | -11.55M (+184.48%) | -4.06M (+38.10%) | -2.94M | 1.41M |
Comprehensive Income Net Of Tax | -19.28M | 14M (-70.13%) | 46M | -10.02M (+93.81%) | -5.17M (-84.91%) | -34.27M (+233.69%) | -10.27M (+40.68%) | -7.30M (+42.58%) | -5.12M (-87.86%) | -42.17M (+726.86%) | -5.10M (-25.87%) | -6.88M (-6.39%) | -7.35M (-60.78%) | -18.74M | - | - | - | - | - | - | - |